ORG Wealth Partners LLC Decreases Stake in Zoetis Inc. (NYSE:ZTS)

ORG Wealth Partners LLC lessened its stake in shares of Zoetis Inc. (NYSE:ZTS) by 4.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,000 shares of the company’s stock after selling 87 shares during the quarter. ORG Wealth Partners LLC’s holdings in Zoetis were worth $326,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in ZTS. Mizuho Securities USA LLC boosted its position in Zoetis by 13,726.9% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company’s stock valued at $950,524,000 after buying an additional 4,829,815 shares during the period. International Assets Investment Management LLC boosted its holdings in shares of Zoetis by 41,235.7% during the third quarter. International Assets Investment Management LLC now owns 939,974 shares of the company’s stock worth $183,652,000 after purchasing an additional 937,700 shares during the period. Marshall Wace LLP increased its holdings in Zoetis by 7,608.6% during the 2nd quarter. Marshall Wace LLP now owns 835,684 shares of the company’s stock valued at $144,874,000 after purchasing an additional 824,843 shares during the period. Nordea Investment Management AB raised its position in Zoetis by 38.3% during the 4th quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock valued at $336,266,000 after purchasing an additional 572,511 shares during the last quarter. Finally, Holocene Advisors LP purchased a new stake in Zoetis in the 3rd quarter worth approximately $110,809,000. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the topic of several research analyst reports. Leerink Partners initiated coverage on Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price on the stock. UBS Group started coverage on shares of Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price objective for the company. Stifel Nicolaus reduced their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday. JPMorgan Chase & Co. raised their price objective on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, Zoetis presently has a consensus rating of “Buy” and a consensus price target of $211.89.

Zoetis Stock Down 0.8 %

Shares of ZTS traded down $1.39 on Friday, hitting $163.63. 1,094,159 shares of the stock traded hands, compared to its average volume of 2,169,563. Zoetis Inc. has a one year low of $144.80 and a one year high of $200.53. The company has a market capitalization of $73.82 billion, a PE ratio of 30.76, a P/E/G ratio of 2.91 and a beta of 0.89. The business has a 50 day simple moving average of $172.08 and a 200 day simple moving average of $180.20. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTS) last posted its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.12. The business had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.36 EPS. As a group, equities analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.22%. This is a boost from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis’s dividend payout ratio is presently 37.59%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.